Cardio Diagnostics Holdings Inc (CDIO)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $5.59M
Last updated: Nov 17, 2026 at 11:02 AM ET
Cardio Diagnostics Holdings Inc (CDIO) Competitors
The companies most similar to Cardio Diagnostics Holdings are Cadrenal Therapeutics, Inc. Common Stock (CVKD), Biocardia (BCDA) and SeaStar Medical Holding (ICU). By market cap, Cardio Diagnostics Holdings ranks 5th of the 13 companies on this page; Biocardia (BCDA) is the largest at $12.58M.
Peer Comparison
CDIO's revenue growth of 25.7% is above the peer median of 0.0%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Cardio Diagnostics Holdings (CDIO) | $5.59M | N/A | 348.9x | 0.0% | N/A | 25.7% | 0.00% |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD) | $5.39M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Biocardia Inc (BCDA) | $12.58M | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| SeaStar Medical Holding Corporation (ICU) | $4.46M | N/A | 1.7x | 0.0% | N/A | 82.0% | 0.00% |
| Kiora Pharmaceuticals Inc (KPRX) | $5.44M | N/A | 6.2x | 0.0% | N/A | 0.0% | 0.00% |
| PharmaCyte Biotech Inc (PMCB) | $3.77M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Creative Medical Technology Holdings Inc (CELZ) | $4.01M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| FibroBiologics, Inc. Common Stock (FBLG) | $6.57M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| CytoMed Therapeutics Limited Ordinary Shares (GDTC) | $9.90M | N/A | 16.4x | 0.0% | -72.3% | -15.9% | 0.00% |
| Imunon Inc (IMNN) | $4.08M | N/A | N/A | 0.0% | -131.5% | 0.0% | 0.00% |
| Senti Biosciences Inc (SNTI) | $5.38M | N/A | 57.2x | 0.0% | 1039.8% | -100.0% | 0.00% |
| Phio Pharmaceuticals Corp (PHIO) | $9.21M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| CNS Pharmaceuticals Inc (CNSP) | $4.22M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Peer median | $5.39M | N/A | 11.3x | 0.0% | -72.3% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Cardio Diagnostics Holdings, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Cadrenal Therapeutics, Inc. Common Stock (CVKD) | Cadrenal Therapeutics, Inc. (CVKD) is a clinical-stage biopharmaceutical firm dedicated to developing groundbreaking therapies for renal diseases and associated... | CVKD competitors |
| Biocardia Inc (BCDA) | BioCardia, Inc., a clinical-stage regenerative medicine company, develops therapies for cardiovascular disease. | BCDA competitors |
| SeaStar Medical Holding Corporation (ICU) | SeaStar Medical Holding Corporation (ICU) is a forward-looking biotechnology company dedicated to innovating treatment solutions for chronic kidney disease via... | ICU competitors |
| Kiora Pharmaceuticals Inc (KPRX) | Kiora Pharmaceuticals Inc. is a clinical-stage biotechnology firm focused on developing innovative therapies for ocular diseases and neurodegenerative... | KPRX competitors |
| PharmaCyte Biotech Inc (PMCB) | PharmaCyte Biotech, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cell therapies for cancer and diabetes in the United... | PMCB competitors |
| Creative Medical Technology Holdings Inc (CELZ) | Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics... | CELZ competitors |
| FibroBiologics, Inc. Common Stock (FBLG) | FibroBiologics, Inc. is an innovative biotechnology company dedicated to advancing regenerative medicine through its proprietary fibroblast cell technology... | FBLG competitors |
| CytoMed Therapeutics Limited Ordinary Shares (GDTC) | CytoMed Therapeutics Limited, a pre-clinical biopharmaceutical company, focuses on developing novel cell-based immunotherapies for the treatment of human... | |
| Imunon Inc (IMNN) | Imunon Inc. is a clinical-stage biotechnology company at the forefront of developing innovative immune-mediated therapies targeting cancer and infectious... | IMNN competitors |
| Senti Biosciences Inc (SNTI) | Senti Biosciences Inc (SNTI) is a leading biotechnology firm specializing in synthetic biology... | SNTI competitors |
| Phio Pharmaceuticals Corp (PHIO) | Phio Pharmaceuticals Corp. The company is headquartered in Marlborough, Massachusetts. | PHIO competitors |
| CNS Pharmaceuticals Inc (CNSP) | CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, is dedicated to the development of cancer drug candidates for the treatment of brain and central... | CNSP competitors |
Frequently Asked Questions About CDIO
Who are Cardio Diagnostics Holdings' main competitors?
The companies most similar to Cardio Diagnostics Holdings include Cadrenal Therapeutics, Inc. Common Stock (CVKD), Biocardia (BCDA), SeaStar Medical Holding (ICU), Kiora Pharmaceuticals (KPRX) and PharmaCyte Biotech (PMCB), listed from the closest match.
Who is Cardio Diagnostics Holdings' biggest competitor?
Biocardia (BCDA) is the largest of the similar companies at $12.58M; Cadrenal Therapeutics, Inc. Common Stock (CVKD) is the closest match by business profile, size, sector and industry.
How does CDIO stock compare with its competitors?
CDIO's P/S is 348.9x against a peer median of 11.3x; its net margin is 0.0% against a peer median of 0.0%.
Which of Cardio Diagnostics Holdings' competitors pays a higher dividend?
Cardio Diagnostics Holdings pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Cardio Diagnostics Holdings bigger than its competitors?
No. Cardio Diagnostics Holdings is 5th by market cap among the 13 companies on this page; the largest is Biocardia (BCDA) at $12.58M.
CDIO pages: Overview, Earnings, Financials, Competitors